
The FDA-CBD Smackdown
$CURA gets some nasty mail from the government. FH looks at the risk to $CWEB, $IAN, $LHS & $TRUL
$CURA gets some nasty mail from the government. FH looks at the risk to $CWEB, $IAN, $LHS & $TRUL
No bottom in sight for Canntrust (TSX:TRST)(NYSE:CTST), and they deserve it. Fundamental Hype on the Canntrust smoking gun. Short Canopy (TSX:WEED)(NYSE:CGC), long Organigram(TSX.V:OGI)(NASDAQ:OGI), and we’re going to tell you why.
We’ve got a dire outlook on $CTST $TRST. Feat. cannabis media all-stars @BettingBruiser & @VanmalaS
The near term prospects for a Linton-less $WEED $CGC don’t look good.
Ianthus CEO Hadley Ford knows a thing or two about banking having scored himself a sweetheart rate on a personal loan from IAN.
Tough Q in Smith Falls. $CGC/$Weed is on the ropes, with $ACB & $OGI closing in. But you can’t dance with the champ, you have to knock him down! Special thx to @goblueCDN, @dsutton1986, @thecannalysts & @KristineOwram.
Two days in, the public listing of $KERN is looking very successful. FH looks into the company’s business, cap table and upside. Featuring @timseymour.
Featuring contributions from @GoBlueCDN, @spearster55, @CUBoulder, @BDSAnalytics, and the one and only @iSmellLikeButts.
Featuring @iandawkins on CDN Cannabis banking, gnashing of teeth among the $N army, and confusion over the $TGOD spinout from @mmjinvesting and @Bartonius
FH has done the deep dive and brought back everything you’ve ever wanted to know about $TRUL, but were afraid to ask.
Copyright © 2023 | WordPress Theme by MH Themes